首页> 外文OA文献 >PMH13 ASSOCIATION OF MEDICATION PERSISTENCE AND HEALTH-CARE UTILIZATION IN HIGH-COST PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE OR VENLAFAXINE XR

【2h】

PMH13 ASSOCIATION OF MEDICATION PERSISTENCE AND HEALTH-CARE UTILIZATION IN HIGH-COST PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE OR VENLAFAXINE XR

机译：接受度洛西汀或文拉法辛XR治疗的伴有严重抑郁障碍的高成本患者PMH13的药物治疗持久性和保健利用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Liu X; Tepper P; Mullins CD; Faries D; Johnstone B;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases [J] . WangJ., LiuX., MullinsC.D. Current medical research and opinion . 2011,第7期

机译：患有严重抑郁症和慢性疼痛相关疾病的患者使用度洛西汀，文拉法辛XR和依西酞普兰治疗依从性和持续性
2. Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland. [J] . Benedict A, Arellano J, De Cock Journal of affective disorders . 2010,第1a3期

机译：都洛西汀与5-羟色胺选择性再摄取抑制剂和文拉法辛XR在苏格兰治疗严重抑郁症的经济评估。
3. Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland. [J] . Benedict A, Arellano J, De Cock E, Journal of affective disorders . 2010,第1a3期

机译：都洛西汀与5-羟色胺选择性再摄取抑制剂和文拉法辛XR在苏格兰治疗严重抑郁症的经济评估。
4. Proteomic investigation of saliva samples from people with major depressive disorder treated with ketamine [C] . Alisa G. Woods, Kelly Wormwood, Armand G Ngounou Wetie, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：氯胺酮治疗重大抑郁症患者唾液样本的蛋白质组学调查
5. Interactive associations of race and comorbidity in medication treatment and outcomes of Medicaid enrolled patients with major depressive disorder. [D] . Wu, Chung-Hsuen. 2010

机译：药物治疗中种族和合并症之间的互动关联以及纳入Medicaid的重度抑郁症患者的结局。
6. Comparing Treatment Persistence Healthcare Resource Utilization and Costs in Adult Patients with Major Depressive Disorder Treated with Escitalopram or Citalopram [O] . Eric Q. Wu, *, Paul E. Greenberg, 2011

机译：依西酞普兰或西酞普兰治疗的重度抑郁症成年患者的治疗持久性医疗资源利用和费用的比较
7. PMH13 Longitudinal Analysis of Patient Level Health Care Costs in Patients With Major Depressive Disorder Treated With Duloxetine [O] . Cui Z., Faries D.E., Shen W., 2012

机译：用度洛西汀治疗重度抑郁症患者的PMH13患者水平医疗保健费用的纵向分析

PMH13 ASSOCIATION OF MEDICATION PERSISTENCE AND HEALTH-CARE UTILIZATION IN HIGH-COST PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE OR VENLAFAXINE XR

著录项

相似文献

相关主题

期刊订阅